Table 2.
2D Nanomaterials | Photothermal Conversion | Therapy | Applied Forms | Ref. |
---|---|---|---|---|
Graphene derivatives | 63% (G), 35% (GO) [59] | PTT, PDT | GO-UCNPs-ZnPc | [61] |
PTT | GO/MnFe2O4/DOX | [62] | ||
TiO2 | 40.8% [86] | PTT | Ag@TiO2 | [82] |
PDT | N-TiO2 | [81] | ||
MoS2 | 0.84% [67] | PTT | MoS2-HA-DTPA-Gd | [71] |
PTT, PDT | AuNBPs@MoS2 | [72] | ||
PTT | MoS2-Gd-BSA | [73] | ||
BP | 30.84% [97] | PTT | BP-Au NSs | [98] |
PTT | BP-PEG-FA/Cy7 NSs | [99] | ||
PTT, PDT | BP@PEG/Ce6 NSs | [100] | ||
Mxene(Ti3C2) | ≒100% [92] | PTT | Ti3C2@Au | [93] |
PTT, PDT | Ti3C2-SP | [94] | ||
PTT, PDT | Ti3C2-DOX | [95] | ||
WS2 | 35% [68] | PTT, PDT | BSA-WS2@MB | [75] |
PTT | WS2-PEG | [76] | ||
PTT | WS2-IO/S@MO-PEG | [77] | ||
MoSe2 | 54.3% [69] | PTT, PDT | MoSe2/Fe3O4 | [79] |
PTT, PDT | MoSe2@PEG-Dox | [80] | ||
2D Boron | 42.5% [104] | PTT, PDT | B@Ce6–PAH–PAA | [105] |
MnO2 | 62.4% [87] | PTT | MnO2-PEG-FA/DOX | [84] |
PTT | BSA-MnO2 NPs | [85] |